Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. [electronic resource]
Producer: 20101217Description: 343-50 p. digitalISSN:- 1365-2710
- 2-Pyridinylmethylsulfinylbenzimidazoles -- administration & dosage
- Adult
- Amoxicillin -- administration & dosage
- Anti-Bacterial Agents -- administration & dosage
- Anti-Ulcer Agents -- administration & dosage
- Aryl Hydrocarbon Hydroxylases -- genetics
- Asian People -- genetics
- Breath Tests -- methods
- Clarithromycin -- administration & dosage
- Cytochrome P-450 CYP2C19
- Drug Resistance, Bacterial
- Dyspepsia -- drug therapy
- Esomeprazole -- administration & dosage
- Female
- Helicobacter Infections -- drug therapy
- Helicobacter pylori -- drug effects
- Hong Kong
- Humans
- Male
- Middle Aged
- Mutation
- Pharmacogenetics
- Polymorphism, Genetic
- Prospective Studies
- Rabeprazole
- Urea -- metabolism
No physical items for this record
Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.